GER Equity Snapshot

GIS Weekly Equity Report

Gilead Sciences, Inc.

Interactive chart JSON snapshot
Latest Close 107.6 EUR 12 Jun 2026
1W Return -5.0% latest completed week
4W Return -3.4% short-term follow-through
12W Return -9.6% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
Company Brief

What the company does

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment …

Snapshot

What the weekly tape is saying

GIS closed the latest completed week at 107.6 EUR. The 4-week return is -3.4% and the 12-week return is -9.6%. Trend Signal is inactive, Market Dynamics is -0.96. Setup signature: Balanced read with a 44/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.9%
Volume 1.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 38 Persistence of active Trend Signal over the last year and current streak.
Momentum 34 Blend of 4-week and 12-week follow-through.
Dynamics 34 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 35 Relative leadership and short-term RS change.
Volume 71 Participation compared with the 13-week volume baseline.
Risk Control 50 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
114.3 EUR
Vs Trend Line
-5.9%
Fair Value
84.11 EUR
Vs Fair Value
28.0%
52W High
131.1 EUR
52W Low
88.00 EUR
Drawdown
-17.9%
Range Position
45.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -5.0%
4W -3.4%
12W -9.6%
26W 4.0%
52W 15.5%

Trend read

Active Streak
0 weeks
52W Active Weeks
36
52W Active Breadth
69.2%
Sector Scope
DE Healthcare
Sector Rank
71 of 80
Sector Percentile
11.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.96
4W MD Change
16.6%
Relative Strength
-1.52
4W RS Change
-125.4%
Expectation
Positive
Probability
56.24%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
7.2K
13W Average
4.3K
52W Average
4.8K
Vs 13W
1.7x
Vs 52W
1.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
2.7%
52W Volatility
3.0%
Upside Weeks
27
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
2.6% / -2.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
GER
Country
DE
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Market Cap
143.3B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 107.6 EUR -5.0% 114.3 EUR 84.11 EUR -0.96 -1.52 7.2K Off
5 Jun 2026 113.3 EUR -1.8% 114.3 EUR 83.83 EUR -1.04 3.32 2.8K Off
29 May 2026 115.4 EUR 0.7% 113.9 EUR 83.52 EUR -1.06 4.11 3.5K Off
22 May 2026 114.6 EUR 2.9% 113.5 EUR 83.19 EUR -1.13 4.61 3.2K Off
15 May 2026 111.4 EUR 0.4% 113.1 EUR 82.87 EUR -1.15 6.00 4.5K Off
8 May 2026 111.0 EUR -1.2% 112.8 EUR 82.58 EUR -1.04 4.33 5.7K On
1 May 2026 112.4 EUR 0.8% 112.4 EUR 82.28 EUR -0.84 6.30 3.0K On
24 Apr 2026 111.5 EUR -4.6% 111.8 EUR 81.97 EUR -0.60 6.57 4.2K On
17 Apr 2026 116.9 EUR -2.3% 111.2 EUR 81.68 EUR -0.33 9.49 3.8K On
10 Apr 2026 119.7 EUR -1.4% 110.5 EUR 81.38 EUR -0.15 16.58 4.2K On
3 Apr 2026 121.3 EUR 2.6% 109.7 EUR 81.04 EUR 0.20 21.80 1.9K On
27 Mar 2026 118.3 EUR -0.6% 108.9 EUR 80.71 EUR 0.41 23.65 8.2K On
20 Mar 2026 119.0 EUR -6.3% 108.1 EUR 80.38 EUR 0.70 24.45 3.3K On
13 Mar 2026 127.0 EUR 3.1% 107.4 EUR 80.04 EUR 1.15 27.39 3.4K On